Literature DB >> 8959142

Time to initiation of anti-tuberculosis treatment.

J E Pirkis1, B R Speed, A P Yung, D R Dunt, C R MacIntyre, A J Plant.   

Abstract

SETTING: Fairfield Hospital, Victoria, Australia.
OBJECTIVE: To examine delay in initiation of treatment for tuberculosis (TB).
DESIGN: Delay in the initiation of treatment for 142 notified TB patients was examined by a retrospective record review. Particular attention was given to the periods between (1) onset of symptoms and initiation of treatment, and (2) determination of sputum positivity and initiation of treatment. An expert panel nominated 30 days and 3 days as 'acceptable' periods for (1) and (2), respectively.
RESULTS: Only 31% of patients commenced treatment within 30 days of onset of symptoms. This was so for both sputum smear-positive and negative cases, and was not significantly related to the site of infection, referral source, age, gender or ethnicity of the patient. Of patients with smear-positive pulmonary TB, 86% received treatment within 3 days of this result being demonstrated. Those with a delay of greater than 3 days were all investigated by private doctors through private laboratories.
CONCLUSION: There are appreciable delays in initiation of treatment for TB. Measures to combat these unacceptable delays are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8959142     DOI: 10.1016/s0962-8479(96)90111-2

Source DB:  PubMed          Journal:  Tuber Lung Dis        ISSN: 0962-8479


  22 in total

Review 1.  Tuberculosis: 11. Nosocomial disease.

Authors:  K Schwartzman; D Menzies
Journal:  CMAJ       Date:  1999-11-16       Impact factor: 8.262

2.  New developments in BCG vaccine: implications for tuberculosis control.

Authors:  C R MacIntyre
Journal:  Epidemiol Infect       Date:  2007-02       Impact factor: 2.451

3.  Delayed tuberculosis treatment in urban and suburban Ontario.

Authors:  Andrea S Gershon; Wendy Wobeser; Jack V Tu
Journal:  Can Respir J       Date:  2008 Jul-Aug       Impact factor: 2.409

4.  Trends in Testing for Mycobacterium tuberculosis Complex From US Public Health Laboratories, 2009-2013.

Authors:  Frances Tyrrell; Cortney Stafford; Mitchell Yakrus; Monica Youngblood; Andrew Hill; Stephanie Johnston
Journal:  Public Health Rep       Date:  2016-12-12       Impact factor: 2.792

5.  Diagnostic and treatment delay among Tuberculosis patients in Afar Region, Ethiopia: a cross-sectional study.

Authors:  Mulugeta Belay; Gunnar Bjune; Gobena Ameni; Fekadu Abebe
Journal:  BMC Public Health       Date:  2012-05-23       Impact factor: 3.295

6.  Factors associated with treatment delay among tuberculosis patients referred from a tertiary hospital in Dhaka City: a cross-sectional study.

Authors:  W Htike; M A Islam; M T Hasan; S Ferdous; M Rifat
Journal:  Public Health Action       Date:  2013-12-21

7.  Diagnosis and treatment delay among pulmonary tuberculosis patients identified using the Taiwan reporting enquiry system, 2002-2006.

Authors:  Hui-Ping Lin; Chung-Yeh Deng; Pesus Chou
Journal:  BMC Public Health       Date:  2009-02-12       Impact factor: 3.295

8.  Treatment Delay among Pulmonary Tuberculosis Patients within the Pakistan National Tuberculosis Control Program.

Authors:  Shahab E Saqib; Mokbul Morshed Ahmad; Carmen Amezcua-Prieto; Martínez-Ruiz Virginia
Journal:  Am J Trop Med Hyg       Date:  2018-05-10       Impact factor: 2.345

9.  Pulmonary tuberculosis in mumbai, India: factors responsible for patient and treatment delays.

Authors:  Ashutosh Tamhane; Girish Ambe; Sten H Vermund; Connie L Kohler; Alka Karande; Nalini Sathiakumar
Journal:  Int J Prev Med       Date:  2012-08

10.  Pulmonary tuberculosis and delay in anti-tuberculous treatment are important risk factors for chronic obstructive pulmonary disease.

Authors:  Chih-Hsin Lee; Ming-Chia Lee; Hsien-Ho Lin; Chin-Chung Shu; Jann-Yuan Wang; Li-Na Lee; Kun-Mao Chao
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.